Cannabinoid Type 2 (CB(2)) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease

The cannabinoid type two receptors (CB(2)), an important component of the endocannabinoid system, have recently emerged as neuromodulators and therapeutic targets for neurodegenerative diseases including Parkinson's disease (PD). The downregulation of CB(2) receptors has been reported in the br...

Descripción completa

Detalles Bibliográficos
Autores principales: Javed, Hayate, Azimullah, Sheikh, Haque, M. Emdadul, Ojha, Shreesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
https://www.ncbi.nlm.nih.gov/pubmed/27531971
http://dx.doi.org/10.3389/fnins.2016.00321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
https://www.ncbi.nlm.nih.gov/pubmed/27531971
http://dx.doi.org/10.3389/fnins.2016.00321

Ejemplares similares